600535 天士力
已收盘 09-30 15:00:00
资讯
新帖
简况
天士力（600535）9月28日主力资金净买入116.00万元
证券之星 · 09-29 08:24
天士力（600535）9月28日主力资金净买入116.00万元
股市必读：天士力新发布《天士力第九届董事会第25次会议决议公告》
证券之星 · 09-28
股市必读：天士力新发布《天士力第九届董事会第25次会议决议公告》
天士力（600535）披露董事会审计委员会委员调整公告，9月24日股价下跌1.51%
证券之星 · 09-24
天士力（600535）披露董事会审计委员会委员调整公告，9月24日股价下跌1.51%
天士力：公司将切实落实“十五五”战略规划中的关键举措
证券之星 · 09-21
天士力：公司将切实落实“十五五”战略规划中的关键举措
天士力：公司拥有在研创新药33项
证券之星 · 09-21
天士力：公司拥有在研创新药33项
研报掘金丨东方证券：维持天士力“买入”评级，核心品种稳健增长，创新管线蓄势待发
格隆汇 · 09-15
研报掘金丨东方证券：维持天士力“买入”评级，核心品种稳健增长，创新管线蓄势待发
天士力（600535）披露2026年半年度利润分配预案，9月7日股价下跌0.75%
证券之星 · 09-07
天士力（600535）披露2026年半年度利润分配预案，9月7日股价下跌0.75%
股市必读：天士力新发布《天士力2026年第二次临时股东会会议资料》
证券之星 · 09-07
股市必读：天士力新发布《天士力2026年第二次临时股东会会议资料》
股市必读：天士力新发布《天士力关于参加2026年天津辖区上市公司投资者网上集体接待日活动的公告》
证券之星 · 08-31
股市必读：天士力新发布《天士力关于参加2026年天津辖区上市公司投资者网上集体接待日活动的公告》
每周股票复盘：天士力（600535）将参加投资者网上集体接待日活动
证券之星 · 08-30
每周股票复盘：天士力（600535）将参加投资者网上集体接待日活动
研报掘金丨中银证券：维持天士力“买入”评级，独家品种纳入基药有望加速放量
格隆汇 · 08-28
研报掘金丨中银证券：维持天士力“买入”评级，独家品种纳入基药有望加速放量
天士力（600535）披露2026年半年度报告，8月24日股价下跌1.0%
证券之星 · 08-24
天士力（600535）披露2026年半年度报告，8月24日股价下跌1.0%
图解天士力中报：第二季度单季净利润同比增长13.48%
证券之星 · 08-22
图解天士力中报：第二季度单季净利润同比增长13.48%
华润医药旗下天士力2026年上半年营收42亿元，同比下降2.03%
美股速递 · 08-21
华润医药旗下天士力2026年上半年营收42亿元，同比下降2.03%
天士力（600535）披露董事长变更公告，8月10日股价下跌0.57%
证券之星 · 08-10
天士力（600535）披露董事长变更公告，8月10日股价下跌0.57%
【投融资动态】霍德生物C轮融资，融资额2亿人民币，投资方为天士力控股集团、海邦投资等
证券之星 · 08-10
【投融资动态】霍德生物C轮融资，融资额2亿人民币，投资方为天士力控股集团、海邦投资等
天士力最新公告：选举蔡金勇为董事长
证券之星 · 08-10
天士力最新公告：选举蔡金勇为董事长
研报掘金丨国盛证券：天士力业绩稳健增长，维持“买入”评级
格隆汇 · 08-06
研报掘金丨国盛证券：天士力业绩稳健增长，维持“买入”评级
每周股票复盘：天士力（600535）2026上半年净利增15.23%
证券之星 · 07-19
每周股票复盘：天士力（600535）2026上半年净利增15.23%
天士力最新公告：子公司注射用重组人尿激酶原获临床试验通知书扩展急性缺血性卒中适应症时间窗
证券之星 · 07-17
天士力最新公告：子公司注射用重组人尿激酶原获临床试验通知书扩展急性缺血性卒中适应症时间窗
加载更多
公司概况
公司名称：
天士力医药集团股份有限公司
所属行业：
医药制造业
上市日期：
2002-08-23
主营业务：
天士力医药集团股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是复方丹参滴丸、养血清脑丸（颗粒）、芪参益气滴丸、水林佳（水飞蓟宾胶囊）、注射用重组人尿激酶原（普佑克）、芍麻止痉颗粒。公司连续多年荣获“中国医药工业百强”、“中国医药创新企业100强”、“中国药品研发综合实力50强”、“中国中药研发实力10强”等称号。
发行价格：
14.70
{"stockData":{"symbol":"600535","market":"SH","secType":"STK","nameCN":"天士力","latestPrice":14,"timestamp":1790751600000,"preClose":13.74,"halted":0,"volume":12576273,"delay":0,"changeRate":0.0189,"floatShares":1494000000,"shares":1494000000,"eps":0.8187,"marketStatus":"已收盘","change":0.26,"latestTime":"09-30 15:00:00","open":13.75,"high":14.1,"low":13.72,"amount":176000000,"amplitude":0.0277,"askPrice":14.01,"askSize":10,"bidPrice":14,"bidSize":1503,"shortable":0,"etf":0,"ttmEps":0.8187,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":13.74,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":15.11,"lowLimit":12.37,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1493950005,"isCdr":false,"pbRate":1.6,"roa":"--","peRate":17.100281,"roe":"6.98%","epsLYR":0.74,"committee":-0.445242,"marketValue":20915000000,"turnoverRate":0.0084,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","floatMarketCap":20915000000},"requestUrl":"/m/hq/s/600535","defaultTab":"news","newsList":[{"id":"2671218266","title":"天士力（600535）9月28日主力资金净买入116.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671218266?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:24","pubTimestamp":1790641457,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，天士力报收于13.8元，上涨0.88%，换手率0.73%，成交量10.93万手，成交额1.5亿元。近5日资金流向一览见下表：天士力融资融券信息显示，融资方面，当日融资买入1974.36万元，融资偿还1557.39万元，融资净买入416.97万元，连续3日净买入累计1035.25万元。天士力主营业务：药品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0012","BK0239","600535","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670090094","title":"股市必读：天士力新发布《天士力第九届董事会第25次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670090094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670090094?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:48","pubTimestamp":1790534894,"startTime":"0","endTime":"0","summary":"公司公告汇总天士力第九届董事会第25次会议决议公告天士力医药集团股份有限公司于2026年9月24日召开第九届董事会第25次会议，审议通过关于调整公司董事会审计委员会委员的议案。调整后审计委员会由王爱俭女士任主任委员，王亮先生、段亚林先生为成员，任期至第九届董事会任期届满。会议应到董事14人，实到14人，表决结果为同意14票，反对0票，弃权0票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0183","BK0196","BK0028","600535","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669525499","title":"天士力（600535）披露董事会审计委员会委员调整公告，9月24日股价下跌1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669525499","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669525499?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:23","pubTimestamp":1790259795,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，天士力报收于13.68元，较前一交易日下跌1.51%，最新总市值为204.37亿元。该股当日开盘13.88元，最高13.9元，最低13.64元，成交额达1.44亿元，换手率为0.7%。近日，天士力医药集团股份有限公司发布第九届董事会第25次会议决议公告。公告显示，公司于2026年9月24日召开第九届董事会第25次会议，审议通过关于调整公司董事会审计委员会委员的议案。会议应到董事14人，实到14人，表决结果为同意14票，反对0票，弃权0票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400041300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600535","BK0183","BK0012","BK0028","BK0196","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669340155","title":"天士力：公司将切实落实“十五五”战略规划中的关键举措","url":"https://stock-news.laohu8.com/highlight/detail?id=2669340155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669340155?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:36","pubTimestamp":1789976205,"startTime":"0","endTime":"0","summary":"证券之星消息，天士力(600535)09月21日在投资者关系平台上答复投资者关心的问题。投资者提问：公司为什么不能进行回购？股价多少年未涨。现阶段分红的意义远比不上回购注销。天士力回复：感谢您的关注，收到您的建议。公司将切实落实“十五五”战略规划中的关键举措，提升公司的经营质量，加快产品研发创新效率，为公司创造长期价值，同时密切关注市场情况，如有回购等相关安排，公司会按照信息披露相关规定及时进行披露，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100014193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0196","BK0239","BK0012","BK0028","600535","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669553711","title":"天士力：公司拥有在研创新药33项","url":"https://stock-news.laohu8.com/highlight/detail?id=2669553711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669553711?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:36","pubTimestamp":1789976203,"startTime":"0","endTime":"0","summary":"证券之星消息，天士力(600535)09月21日在投资者关系平台上答复投资者关心的问题。投资者提问：公司Ⅲ期临床可有重磅产品？天士力回复：感谢您的关注，根据公司2026年半年报，公司拥有在研创新药33项（上半年神经/精神领域新立项2项），其中处于NDA/Pre NDA阶段3项，处于临床II、III期阶段18项。产品详细信息请参考2026年半年报P17页公司重点创新产品研发进度表，谢谢。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100014190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0183","BK0188","BK0196","BK0239","BK0012","06978","BK1574","BK0028","159992","600535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617867","title":"研报掘金丨东方证券：维持天士力“买入”评级，核心品种稳健增长，创新管线蓄势待发","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617867","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667617867?lang=zh_cn&edition=full","pubTime":"2026-09-15 15:48","pubTimestamp":1789458484,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0012","600958","BK0239","BK0276","600535","BK0188","BK0183","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311704","title":"天士力（600535）披露2026年半年度利润分配预案，9月7日股价下跌0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665311704?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:45","pubTimestamp":1788774307,"startTime":"0","endTime":"0","summary":"截至2026年9月7日收盘，天士力（600535）报收于14.62元，较前一交易日下跌0.75%，最新总市值为218.42亿元。该股当日开盘14.75元，最高14.87元，最低14.6元，成交额达1.62亿元，换手率为0.74%。近日，天士力医药集团股份有限公司披露2026年第二次临时股东会会议资料，其中包含2026年半年度利润分配预案：拟每股派发现金红利0.24元（含税），合计派发3.58亿元。最新公告列表《天士力2026年第二次临时股东会会议资料》以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700023027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","BK0188","BK0028","BK0183","BK0196","600535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665784362","title":"股市必读：天士力新发布《天士力2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665784362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665784362?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:00","pubTimestamp":1788714044,"startTime":"0","endTime":"0","summary":"公司公告汇总：天士力拟每股派发现金红利0.24元（含税），合计派发3.58亿元；法定代表人由总经理调整为董事长。公司公告汇总天士力2026年第二次临时股东会会议资料天士力医药集团股份有限公司召开2026年第二次临时股东会，审议增补席凯先生为非独立董事、修订公司章程、2026年半年度利润分配预案、续聘毕马威华振为2026年年度审计机构、使用不超过40亿元闲置资金购买银行理财产品、购买董事及高管责任险等议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600535","BK0196","BK0183","BK0239","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663042736","title":"股市必读：天士力新发布《天士力关于参加2026年天津辖区上市公司投资者网上集体接待日活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663042736","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663042736?lang=zh_cn&edition=full","pubTime":"2026-08-31 03:10","pubTimestamp":1788117019,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，天士力报收于14.89元，上涨0.47%，换手率1.02%，成交量15.26万手，成交额2.27亿元。当日关注点交易信息汇总：8月28日主力资金净流入2317.38万元，占总成交额10.21%。公司公告汇总：天士力将于2026年9月3日通过“全景路演”平台举行投资者网上集体接待日活动，董事长、董秘及财务总监将出席并就半年度业绩及发展战略等与投资者交流。投资者可于2026年9月2日12:00前通过公司邮箱提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600535","BK0183","BK0239","BK0012","BK0196","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010906","title":"每周股票复盘：天士力（600535）将参加投资者网上集体接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010906","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010906?lang=zh_cn&edition=full","pubTime":"2026-08-30 02:59","pubTimestamp":1788029947,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，天士力报收于14.89元，较上周的14.97元下跌0.53%。本周，天士力8月28日盘中最高价报15.04元。本周关注点来自公司公告汇总：天士力将参加2026年天津辖区上市公司投资者网上集体接待日活动公司公告汇总天士力医药集团股份有限公司将参加由天津证监局指导，天津上市公司协会与深圳市全景网络有限公司联合举办的“2026年天津辖区上市公司投资者网上集体接待日活动”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600535","BK0183","BK0012","BK0028","BK0196","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662906304","title":"研报掘金丨中银证券：维持天士力“买入”评级，独家品种纳入基药有望加速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2662906304","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662906304?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:26","pubTimestamp":1787909213,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","BK0276","601696","BK0188","600535","BK0196","BK0183","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220253","title":"天士力（600535）披露2026年半年度报告，8月24日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220253?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:18","pubTimestamp":1787566735,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，天士力报收于14.82元，较前一交易日下跌1.0%，最新总市值为221.4亿元。该股当日开盘14.99元，最高15.03元，最低14.68元，成交额达2.53亿元，换手率为1.14%。近日，天士力医药集团股份有限公司披露2026年半年度报告。公告显示，截至2026年6月30日，公司总资产为15,301,767,667.66元，较上年度末减少0.25%；归属于上市公司股东的净资产为13,076,260,034.86元，同比增长5.42%。基本每股收益0.60元，同比增长15.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600535","BK0183","BK0028","BK0196","BK0188","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294768","title":"图解天士力中报：第二季度单季净利润同比增长13.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294768","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661294768?lang=zh_cn&edition=full","pubTime":"2026-08-22 01:44","pubTimestamp":1787334259,"startTime":"0","endTime":"0","summary":"证券之星消息，天士力2026年中报显示，上半年度公司主营收入42.01亿元，同比下降2.03%；归母净利润8.93亿元，同比上升15.23%；扣非净利润8.7亿元，同比上升36.0%；其中2026年第二季度，公司单季度主营收入20.36亿元，同比下降8.82%；单季度归母净利润5.22亿元，同比上升13.48%；单季度扣非净利润5.06亿元，同比上升25.33%；负债率13.68%，投资收益-1816.56万元，财务费用-1753.58万元，毛利率69.56%。财报数据概要请见下图:本文数据来源于天士力2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200001981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126546162","title":"华润医药旗下天士力2026年上半年营收42亿元，同比下降2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126546162","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126546162?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:45","pubTimestamp":1787309139,"startTime":"0","endTime":"0","summary":"华润医药披露的数据显示，其旗下天士力在2026年上半年实现营收42亿元人民币，较去年同期下滑2.03%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0188","BK0183","BK0028","BK0239","BK0012","BK1191","BK1570","600535","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658934028","title":"天士力（600535）披露董事长变更公告，8月10日股价下跌0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658934028","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658934028?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:07","pubTimestamp":1786370875,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，天士力报收于15.63元，较前一交易日下跌0.57%，最新总市值为233.5亿元。近日，天士力发布《关于董事长变更的公告》。公告显示，因工作调整原因，周辉女士不再担任天士力医药集团股份有限公司董事长职务，但仍继续担任公司董事及董事会相关委员会委员。周辉女士未持有公司股票，不存在未履行完毕的承诺事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000033704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600535","BK0183","BK0028","BK0196","BK0188","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933128","title":"【投融资动态】霍德生物C轮融资，融资额2亿人民币，投资方为天士力控股集团、海邦投资等","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658933128?lang=zh_cn&edition=full","pubTime":"2026-08-10 19:26","pubTimestamp":1786361178,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP于8月9日公布的信息整理，浙江霍德生物工程有限公司C轮融资，融资额2亿人民币，参与投资的机构包括天士力控股集团，海邦投资，广州健康产投，隆门资本。霍德生物是由美国约翰霍普金斯大学的神经及干细胞科学家联合于2017年1月在杭州创立，依托其在人iPSCs/ESCs的神经分化及细胞工程等方面的优势，已经完成A融资。公司在杭州拥有1400平米生产、研发及办公基地，满足GLP/GMP的千级净化细胞实验室。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000028012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0196","BK0183","BK0239","CYB","MUCmain","BK0188","UCmain","600535","MCNHmain","CNHmain","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658829169","title":"天士力最新公告：选举蔡金勇为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2658829169","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658829169?lang=zh_cn&edition=full","pubTime":"2026-08-10 17:43","pubTimestamp":1786355030,"startTime":"0","endTime":"0","summary":"天士力(600535.SH)公告称，因工作调整，周辉不再担任董事长职务，继续担任公司董事及专门委员会委员。经董事会审议通过，选举非独立董事蔡金勇为第九届董事会董事长，任期至本届董事会届满。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000023300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0188","BK0239","BK0028","BK0196","BK0012","600535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657502291","title":"研报掘金丨国盛证券：天士力业绩稳健增长，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502291","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657502291?lang=zh_cn&edition=full","pubTime":"2026-08-06 14:19","pubTimestamp":1785997165,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0276","BK0052","BK0239","BK0012","BK0188","BK0028","002670","BK0183","BK0196","600535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652623742","title":"每周股票复盘：天士力（600535）2026上半年净利增15.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652623742","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652623742?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:36","pubTimestamp":1784396171,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，天士力报收于15.38元，较上周的14.08元上涨9.23%。本周，天士力7月16日盘中最高价报16.0元。本周关注点业绩披露要点：天士力2026年上半年归母净利润达8.927亿元，同比增长15.23%。公司公告汇总天士力医药集团股份有限公司发布2026年半年度业绩快报，营业总收入420,105.38万元，同比下降2.03%；营业利润104,776.27万元，同比增长14.87%；归属于上市公司股东的净利润89,268.22万元，同比增长15.23%；扣除非经常性损益后的净利润87,053.69万元，同比增长36.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600535","BK0183","BK0028","BK0196","BK0188","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652404835","title":"天士力最新公告：子公司注射用重组人尿激酶原获临床试验通知书扩展急性缺血性卒中适应症时间窗","url":"https://stock-news.laohu8.com/highlight/detail?id=2652404835","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652404835?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:51","pubTimestamp":1784281886,"startTime":"0","endTime":"0","summary":"天士力(600535.SH)公告称，公司全资子公司天士力生物收到国家药监局核准签发的《药品临床试验通知书》，获批开展注射用重组人尿激酶原(普佑克)用于发病4.5至24小时急性缺血性卒中患者的临床试验。该药品为1类生物创新药，此前已获批用于发病4.5小时内患者的静脉溶栓治疗。截至目前，相关研发投入为54.85万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700033037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","600535","BK0183","BK0012","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790894617285,"stockEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0463},{"period":"3month","weight":0.0174},{"period":"6month","weight":-0.0152},{"period":"1year","weight":-0.0957},{"period":"ytd","weight":-0.0642}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"天士力医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"62959人(较上一季度减少11.24%)","perCapita":"23728股","listingDate":"2002-08-23","address":"天津市北辰区普济河东道2号(天士力现代中药城)","registeredCapital":"149395万元","survey":" 天士力医药集团股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是复方丹参滴丸、养血清脑丸（颗粒）、芪参益气滴丸、水林佳（水飞蓟宾胶囊）、注射用重组人尿激酶原（普佑克）、芍麻止痉颗粒。公司连续多年荣获“中国医药工业百强”、“中国医药创新企业100强”、“中国药品研发综合实力50强”、“中国中药研发实力10强”等称号。","listedPrice":14.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天士力(600535)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天士力(600535)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天士力,600535,天士力股票,天士力股票老虎,天士力股票老虎国际,天士力行情,天士力股票行情,天士力股价,天士力股市,天士力股票价格,天士力股票交易,天士力股票购买,天士力股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天士力(600535)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天士力(600535)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}